The principal objective in a new drug development program is to assess the benefit / risk ratio. Learn what the risk information is that must be collected, documented and reported accurately.
The Risk to Subject Safety of Not Accurately Reporting Adverse Events - How to Assess and report AEs and SAEs - By GlobalCompliancePanel
14 June 2011, Wilmington, United States
Introduction
Venue
Online Training Webinars
Online Training Webinars, 1000 N West Street | Suite 1200, Wilmington, 19801, United States
Useful links
Contact information
Mr
United States of America
United States of America
Related events
Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
RSC Energy Sector Next Generation Materials for Solar Photovoltaics 2025
16 January 2025, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
